Stay current with the latest news on Blood Cancer United research programs, FDA approvals, research grants and awards, the Therapy Acceleration Program, Beat AML and other clinical research programs, and more.
News
FDA Approves New Drug for the Most Common Form of Leukemia in Adults
The U.S. Food and Drug Administration has approved pirtobrutinib (Jaypirca™). Pirtobrutinib is the only FDA-approved non-covalent, reversable Bruton’s…